HealthEquity, Inc. $HQY Stock Sold by William Blair Investment Management LLC

William Blair Investment Management LLC cut its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 1.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,740,078 shares of the company’s stock after selling 33,149 shares during the quarter. William Blair Investment Management LLC owned 2.10% of HealthEquity worth $153,927,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Signaturefd LLC grew its holdings in shares of HealthEquity by 11.7% during the third quarter. Signaturefd LLC now owns 1,359 shares of the company’s stock worth $120,000 after purchasing an additional 142 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of HealthEquity by 12.0% in the third quarter. GAMMA Investing LLC now owns 1,479 shares of the company’s stock valued at $131,000 after buying an additional 158 shares during the period. State of Wyoming raised its holdings in HealthEquity by 4.3% in the 3rd quarter. State of Wyoming now owns 4,350 shares of the company’s stock valued at $385,000 after buying an additional 181 shares during the last quarter. Fifth Third Bancorp raised its holdings in HealthEquity by 0.8% in the 3rd quarter. Fifth Third Bancorp now owns 23,363 shares of the company’s stock valued at $2,067,000 after buying an additional 190 shares during the last quarter. Finally, Cim Investment Management Inc. raised its holdings in HealthEquity by 5.0% in the 2nd quarter. Cim Investment Management Inc. now owns 4,007 shares of the company’s stock valued at $362,000 after buying an additional 191 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

Insider Transactions at HealthEquity

In related news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total value of $798,383.52. Following the transaction, the director owned 62,395 shares in the company, valued at $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by insiders.

HealthEquity Price Performance

Shares of NASDAQ HQY opened at $103.46 on Monday. The company has a market capitalization of $8.56 billion, a P/E ratio of 37.35, a price-to-earnings-growth ratio of 1.63 and a beta of 0.22. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $110.26. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.99 and a current ratio of 2.99. The company’s 50 day moving average price is $96.08 and its 200-day moving average price is $89.97.

HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Thursday, August 27th. The company reported $1.24 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company had revenue of $350.73 million for the quarter, compared to analyst estimates of $349.22 million. HealthEquity’s quarterly revenue was up 95.5% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. Equities analysts forecast that HealthEquity, Inc. will post 3.94 earnings per share for the current year.

Analyst Ratings Changes

Several equities research analysts recently commented on HQY shares. BMO Capital Markets lifted their target price on shares of HealthEquity from $105.00 to $125.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a research report on Thursday, September 3rd. Weiss Ratings raised shares of HealthEquity from a “buy (b-)” rating to a “buy (b)” rating in a research note on Monday, November 2nd. Barclays raised their price target on shares of HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday, September 18th. Finally, Deutsche Bank lifted their price target on shares of HealthEquity from $135.00 to $142.00 and gave the stock a “buy” rating in a report on Monday, August 31st. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $113.53.

Get Our Latest Research Report on HQY

HealthEquity Company Profile

(Free Report)

HealthEquity, Inc. provides technology and services for health savings accounts (HSAs) and other consumer-directed benefits. Its platform supports employers, health plans, benefits advisers and individuals in managing health-related accounts and benefits. Alongside HSAs, the company administers flexible spending accounts, health reimbursement arrangements, commuter benefits and other workplace benefit programs. Its services include account administration, payment tools, customer support and investment options for eligible HSA funds.

Featured Stories

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.